Register entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 2
- Countries
- 0
Exclusivity
Patents and exclusivities
2| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 11027072 | ZIMHInaloxone hydrochloride | product | May 2039 |
| 11571518 | ZIMHInaloxone hydrochloride | product | Jun 2041 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| ZIMHI | Naloxone Hydrochloride | injection, solution, intramuscular, subcutaneous | 84571-140NDA |
Compare
Other companies listing naloxone hydrochloride
- Dr. Reddy's Laboratories Limited15 sites · 683 NDC
- Siegfried USA, LLC12 sites · 54 NDC
- Teva Pharmaceutical Industries Ltd.6 sites · 668 NDC
- Spectrum Pharmaceuticals, Inc.6 sites · 240 NDC
- Par Health USA, LLC5 sites · 211 NDC
- Hikma Pharmaceuticals USA Inc.4 sites · 763 NDC
- International Medication Systems, Ltd.3 sites · 2,801 NDC
- ProPharma Distribution, LLC.3 sites · 100 NDC
- BPI Labs, DBA Ally Labs2 sites · 37 NDC
- Proficient Rx LP1 site · 1,729 NDC
Enquiry
Common questions
- Is ZMI Pharma Inc. FDA approved?
- ZMI Pharma Inc. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does ZMI Pharma Inc. make?
- 1 product is listed under ZMI Pharma Inc. in the openFDA NDC Directory, most often as injection, solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.